Shivani Sud
YOU?
Author Swipe
View article: Supplementary Figure S4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S4
View article: Supplementary Table S4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S4
View article: Supplementary Figure S6 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S6 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S6
View article: Supplementary Figure S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S3
View article: Supplementary Table S2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S2
View article: Supplementary Figure S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S1
View article: Supplementary Figure S5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S5
View article: Supplementary Table S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S1
View article: Supplementary Figure S2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S2
View article: Supplementary Table S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S3
View article: Increased frequency of remote and off-site work impacts incident learning workflows in radiation oncology
Increased frequency of remote and off-site work impacts incident learning workflows in radiation oncology Open
View article: Figure 5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Figure 5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Prognostic value of the smoking and XRT signatures in TCGA and proposed scheme of RT-associated bladder cancer development. The Pearson correlation between the UNC signature motif frequency profile and TCGA BLCA samples was calculated, and…
View article: Supplementary Table S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S1
View article: Supplementary Table S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S3
View article: Figure 5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Figure 5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Prognostic value of the smoking and XRT signatures in TCGA and proposed scheme of RT-associated bladder cancer development. The Pearson correlation between the UNC signature motif frequency profile and TCGA BLCA samples was calculated, and…
View article: Supplementary Figure S5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S5 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S5
View article: Table 2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Table 2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Summary of clinical variables within the radiation therapy cohort, grouped by latency.
View article: Table 2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Table 2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Summary of clinical variables within the radiation therapy cohort, grouped by latency.
View article: Table 1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Table 1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Summary of clinical variables for the control (CTRL) and radiation therapy (RT) cohorts.
View article: Table 1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Table 1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Summary of clinical variables for the control (CTRL) and radiation therapy (RT) cohorts.
View article: Supplementary Figure S6 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S6 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S6
View article: Figure 4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Figure 4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Comparison of the copy number landscape between CTRL and RT tumors. A, Copy number status, as determined by the FoundationOne CDx assay, was plotted by the number of tumors with a given alteration (gains = positive value, losses = n…
View article: Data from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Data from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Radiotherapy (RT) for prostate cancer has been associated with an increased risk for the development of bladder cancer. We aimed to integrate clinical and genomic data to better understand the development of RT-associated bladder cancer. A…
View article: Supplementary Table S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S1
View article: Figure 4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Figure 4 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Comparison of the copy number landscape between CTRL and RT tumors. A, Copy number status, as determined by the FoundationOne CDx assay, was plotted by the number of tumors with a given alteration (gains = positive value, losses = n…
View article: Supplementary Table S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S3
View article: Supplementary Figure S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S1
View article: Supplementary Table S2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Table S2 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Table S2
View article: Figure 1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Figure 1 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Construction and clinical characterization of the RT and CTRL cohorts. A, Flowchart representing identification and filtering of patients included or excluded in each cohort. Barplots of distribution of (B) T, (C) N, a…
View article: Supplementary Figure S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
Supplementary Figure S3 from Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features Open
Supplementary Figure S3